Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016–2017 is a dataset published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 1.5, placing it in the top 13.4% of the data-sharing corpus. It has been cited 47 times, with 37 citing works in its 1-hop citation network.
Ranks in the top 13% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.581
From this paper's citation signal
Citation Network Contribution
0.966
From 29 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 37 citers.
National Institutes of Health
Grant: P30CA240139
NIDA NIH HHS
Grant: DP2 DA053720
NIAID NIH HHS
Grant: P30 AI073961
National Institutes of Health
Grant: 3P30CA240139-02S3
The Sylvester Cancer Center Support Grant
FWCI
3.29
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Syringe services program staff and participant perspectives on changing drug consumption behaviors in response to xylazine adulteration
Additional file 1 of Syringe services program staff and participant perspectives on changing drug consumption behaviors in response to xylazine adulteration
Additional file 2 of Syringe services program staff and participant perspectives on changing drug consumption behaviors in response to xylazine adulteration
Additional file 2 of Syringe services program staff and participant perspectives on changing drug consumption behaviors in response to xylazine adulteration